Gene Details



MYH7 and homologs in 6 species are found in 616 GeneSets:


- Entrez   - Ensembl   - GeneNetwork   - STRING   - Comparative Toxicogenomics Database  

Select gene sets below using the check boxes, and then add them to a project using the pull down below. You can also create a project using the pull down. To view a set, click on the GeneSetID:GeneSet Description shown in green below.
GS185131: GO:0044699 single-organism process
GS187248: GO:0072359 circulatory system development
GS174327: HP:0003198 Myopathy
GS866: Linear decrease in expression in both Pax6 (Sey) mutants and controls.
GS176649: HP:0009077 Weakness of long finger extensor muscles
GS190265: GO:0006928 cellular component movement
GS208901: GO:0005859 muscle myosin complex
GS174646: HP:0000951 Abnormality of the skin
GS136852: Theiler's murine encephalomyelitis virus induced demyelinating disease susceptibility 3 (Tmevd3, Published QTL Chr 14)
GS204629: GO:1901564 organonitrogen compound metabolic process
GS136327: non-insulin-dependent diabetes mellitus 2 in NSY (Nidd2n, Published QTL Chr 14)
GS185985: GO:0016818 hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides
GS201949: GO:0044699 single-organism process
GS124591: N(6)-phenyl-cAMP interacting genes (MeSH:C483758) in CTD
GS205510: GO:0001883 purine nucleoside binding
GS208954: GO:0006139 nucleobase-containing compound metabolic process
GS172666: HP:0011804 Abnormality of muscle physiology
GS135493: behavioral response to methamphetamines 9 (Brmth9, Published QTL Chr 14)
GS207431: GO:0005925 focal adhesion
GS171644: HP:0011842 Abnormality of skeletal morphology
GS201430: GO:0005516 calmodulin binding
GS136598: resistance to thymic deletion 4 (Rthyd4, Published QTL Chr 14)
GS184628: GO:0005516 calmodulin binding
GS189855: GO:0043168 anion binding
GS181223: GO:0046434 organophosphate catabolic process
GS178461: GO:0009987 cellular process
GS87104: Table S2: List of all probe sets differentially expressed between treatment groups with q < 0.05. [DRG] provisional
GS193061: GO:0044444 cytoplasmic part
GS192624: GO:0043231 intracellular membrane-bounded organelle
GS184832: GO:0030898 actin-dependent ATPase activity
GS188698: GO:0003012 muscle system process
GS186743: GO:0043227 membrane-bounded organelle
GS208912: GO:0046700 heterocycle catabolic process
GS135405: body growth late QTL 15 (Bglq15, Published QTL Chr 14)
GS190997: GO:0044281 small molecule metabolic process
GS210507: GO:0006950 response to stress
GS186240: GO:0009146 purine nucleoside triphosphate catabolic process
GS182852: GO:0005198 structural molecule activity
GS197054: GO:0006195 purine nucleotide catabolic process
GS174002: HP:0000189 Narrow palate
GS184984: GO:0032553 ribonucleotide binding
GS193761: GO:0070252 actin-mediated cell contraction
GS193268: GO:0005575 cellular_component
GS173786: HP:0003457 EMG abnormality
GS194039: GO:1901363 heterocyclic compound binding
GS136342: nicotine induced locomotor activity 8 (Nilac8, Published QTL Chr 14)
GS183645: GO:0017076 purine nucleotide binding
GS188190: GO:0006807 nitrogen compound metabolic process
GS196934: GO:0065008 regulation of biological quality
GS194646: GO:0042803 protein homodimerization activity
GS171839: HP:0003458 EMG: myopathic abnormalities
GS136307: myocardial infarction 2 (Myci2, Published QTL Chr 14)
GS199322: GO:0002027 regulation of heart rate
GS175815: HP:0011025 Abnormality of cardiovascular system physiology
GS207581: GO:0007275 multicellular organismal development
GS170968: HP:0000156 High-arched palate
GS172908: HP:0002450 Abnormality of the motor neurons
GS199273: GO:0043233 organelle lumen
GS123134: Forskolin interacting genes (MeSH:D005576) in CTD
GS171902: HP:0010987 Abnormality of cellular immune system
GS172701: HP:0002650 Scoliosis
GS191019: GO:0034641 cellular nitrogen compound metabolic process
GS205002: GO:0048856 anatomical structure development
GS197443: GO:0032549 ribonucleoside binding
GS186265: GO:0003229 ventricular cardiac muscle tissue development
GS84278: chronic alcohol withdrawal severity (Published QTL, Chr 14)
GS177261: GO:0048738 cardiac muscle tissue development
GS202188: GO:0044248 cellular catabolic process
GS174494: HP:0002564 Malformation of the heart and great vessels
GS191088: GO:0009199 ribonucleoside triphosphate metabolic process
GS205610: GO:0044430 cytoskeletal part
GS170783: HP:0010974 Abnormality of myeloid leukocytes
GS180134: GO:0046128 purine ribonucleoside metabolic process
GS203110: GO:0003229 ventricular cardiac muscle tissue development
GS125731: nitrofen interacting genes (MeSH:C007350) in CTD
GS174796: HP:0009054 Scapuloperoneal myopathy
GS182903: GO:0007512 adult heart development
GS204630: GO:1901565 organonitrogen compound catabolic process
GS172581: HP:0003697 Scapuloperoneal amyotrophy
GS178814: GO:0046982 protein heterodimerization activity
GS190539: GO:0005925 focal adhesion
GS189350: GO:0042454 ribonucleoside catabolic process
GS192672: GO:0055086 nucleobase-containing small molecule metabolic process
GS199704: GO:0007512 adult heart development
GS177585: GO:0003206 cardiac chamber morphogenesis
GS200490: GO:0061061 muscle structure development
GS171639: HP:0003704 Scapuloperoneal weakness
GS201023: GO:0071704 organic substance metabolic process
GS180122: GO:0009203 ribonucleoside triphosphate catabolic process
GS136040: insulin dependent diabetes susceptibility 12 (Idd12, Published QTL Chr 14)
GS195875: GO:0030049 muscle filament sliding
GS192017: GO:0006139 nucleobase-containing compound metabolic process
GS196343: GO:0036094 small molecule binding
GS170964: HP:0000152 Abnormality of head and neck
GS190628: GO:0003779 actin binding
GS174445: HP:0001435 Abnormality of the shoulder girdle musculature
GS180276: GO:0006195 purine nucleotide catabolic process
GS191106: GO:0044464 cell part
GS173290: HP:0011354 Generalized abnormality of skin
GS210137: GO:0016462 pyrophosphatase activity
GS177404: GO:0005737 cytoplasm
GS177265: GO:0048731 system development
GS208893: GO:0005856 cytoskeleton
GS201251: GO:0044424 intracellular part
GS127205: Tamoxifen interacting genes (MeSH:D013629) in CTD
GS172031: HP:0000364 Hearing abnormality
GS209401: GO:0046130 purine ribonucleoside catabolic process
GS198972: GO:0006152 purine nucleoside catabolic process
GS188142: GO:0048856 anatomical structure development
GS174226: HP:0001446 Abnormality of the musculature of the upper limbs
GS136293: modifier of obesity related sterility 3 (Mors3, Published QTL Chr 14)
GS86499: Table S2: List of all probe sets differentially expressed between treatment groups with q < 0.05. [DRG] provisional
GS176840: HP:0001911 Abnormality of granulocytes
GS190368: GO:0042623 ATPase activity, coupled
GS196894: GO:0009207 purine ribonucleoside triphosphate catabolic process
GS207523: GO:0003779 actin binding
GS178909: GO:0017111 nucleoside-triphosphatase activity
GS174448: HP:0001430 Abnormality of the calf musculature
GS171453: HP:0003674 Onset
GS177311: GO:1901361 organic cyclic compound catabolic process
GS129081: atherosclerosis 13 (Ath13 Published QTL Chr 14)
GS209551: GO:0031981 nuclear lumen
GS136682: skull morphology 21 (Skull21, Published QTL Chr 14)
GS175389: HP:0011006 Abnormality of the musculature of the neck
GS194555: GO:0031974 membrane-enclosed lumen
GS188701: GO:0003015 heart process
GS123368: Ramipril interacting genes (MeSH:D017257) in CTD
GS171642: HP:0003700 Generalized amyotrophy
GS209108: GO:0000166 nucleotide binding
GS176601: HP:0003803 Type 1 muscle fiber predominance
GS192074: GO:1901575 organic substance catabolic process
GS194966: GO:0046034 ATP metabolic process
GS180118: GO:0009207 purine ribonucleoside triphosphate catabolic process
GS201644: GO:0030898 actin-dependent ATPase activity
GS203608: GO:0034655 nucleobase-containing compound catabolic process
GS181721: GO:0006163 purine nucleotide metabolic process
GS177565: GO:0009166 nucleotide catabolic process
GS188652: GO:0001882 nucleoside binding
GS185585: GO:0044710 single-organism metabolic process
GS208928: GO:0030018 Z disc
GS174073: HP:0009127 Abnormality of the musculature of the limbs
GS177567: GO:0009164 nucleoside catabolic process
GS206726: GO:0009261 ribonucleotide catabolic process
GS175601: HP:0002086 Abnormality of the respiratory system
GS136456: postnatal body weight growth 18 (Pbwg18, Published QTL Chr 14)
GS170933: HP:0001288 Gait disturbance
GS171999: HP:0001760 Abnormality of the foot
GS201799: GO:0032550 purine ribonucleoside binding
GS201800: GO:0032553 ribonucleotide binding
GS194455: GO:0051239 regulation of multicellular organismal process
GS171643: HP:0003701 Proximal muscle weakness
GS171944: HP:0003324 Generalized muscle weakness
GS188757: GO:0009887 organ morphogenesis
GS172853: HP:0004303 Abnormality of muscle fibers
GS87378: Table S2: The data provided represent genes showing differential expression using ANOVA. (Whole Table) [DRG] provisional
GS135853: femoral bone morphometry 2 (Fembm2, Published QTL Chr 14)
GS175993: HP:0000467 Neck muscle weakness
GS188651: GO:0001883 purine nucleoside binding
GS198624: GO:0033275 actin-myosin filament sliding
GS189106: GO:0008015 blood circulation
GS180156: GO:0065008 regulation of biological quality
GS197892: GO:0043228 non-membrane-bounded organelle
GS84279: METH responses for climbing (Published QTL, Chr 14)
GS210139: GO:0016460 myosin II complex
GS194326: GO:0003208 cardiac ventricle morphogenesis
GS182527: GO:0002027 regulation of heart rate
GS190629: GO:0003774 motor activity
GS192299: GO:0006793 phosphorus metabolic process
GS175362: HP:0011916 Toe extensor amyotrophy
GS175390: HP:0011007 Age of onset
GS179123: GO:0060415 muscle tissue morphogenesis
GS189443: GO:0044449 contractile fiber part
GS196808: GO:0032501 multicellular organismal process
GS171708: HP:0000359 Abnormality of the inner ear
GS178401: GO:0019637 organophosphate metabolic process
GS186744: GO:0043226 organelle
GS189316: GO:0060537 muscle tissue development
GS191989: GO:0030018 Z disc
GS206312: GO:0044449 contractile fiber part
GS182835: GO:0005622 intracellular
GS204511: GO:0048729 tissue morphogenesis
GS202415: GO:0044710 single-organism metabolic process
GS213074: Genes with suggestive difference in (B6PF1) vs (PB6F1 + B6 + PWD) comparison
GS207903: GO:0044281 small molecule metabolic process
GS194613: GO:0008092 cytoskeletal protein binding
GS171253: HP:0002817 Abnormality of the upper limb
GS204108: GO:0072358 cardiovascular system development
GS207995: GO:0009199 ribonucleoside triphosphate metabolic process
GS182576: GO:0042641 actomyosin
GS194133: GO:0005737 cytoplasm
GS203406: GO:0009653 anatomical structure morphogenesis
GS186790: GO:0006725 cellular aromatic compound metabolic process
GS207389: GO:0009150 purine ribonucleotide metabolic process
GS177870: GO:0008092 cytoskeletal protein binding
GS194111: GO:0097159 organic cyclic compound binding
GS198725: GO:0003231 cardiac ventricle development
GS189860: GO:0043167 ion binding
GS175525: HP:0000004 Onset and clinical course
GS191129: GO:0016787 hydrolase activity
GS177583: GO:0003205 cardiac chamber development
GS179789: GO:0005730 nucleolus
GS204054: GO:0044057 regulation of system process
GS209187: GO:0005912 adherens junction
GS178216: GO:0046034 ATP metabolic process
GS195199: GO:0005634 nucleus
GS172000: HP:0001761 Pes cavus
GS171752: HP:0001713 Abnormality of cardiac ventricle
GS206742: GO:0043167 ion binding
GS206781: GO:0009116 nucleoside metabolic process
GS135777: epistatic circling SWR/J (ecs, Published QTL Chr 14)
GS198270: GO:0055010 ventricular cardiac muscle tissue morphogenesis
GS135363: B.burgdorferi-associated arthritis 21 (Bbaa21, Published QTL Chr 14)
GS202828: GO:0016817 hydrolase activity, acting on acid anhydrides
GS205560: GO:0003015 heart process
GS195668: GO:0042221 response to chemical stimulus
GS171924: HP:0100578 Lipoatrophy
GS122551: Zinc Sulfate interacting genes (MeSH:D019287) in CTD
GS209010: GO:1901575 organic substance catabolic process
GS126584: Tetrachlorodibenzodioxin interacting genes (MeSH:D013749) in CTD
GS181832: GO:0033275 actin-myosin filament sliding
GS195571: GO:0046982 protein heterodimerization activity
GS171815: HP:0001574 Abnormality of the integument
GS185492: GO:0050789 regulation of biological process
GS188699: GO:0003013 circulatory system process
GS194302: GO:0009166 nucleotide catabolic process
GS194584: GO:0048644 muscle organ morphogenesis
GS186238: GO:0009144 purine nucleoside triphosphate metabolic process
GS179111: GO:0030048 actin filament-based movement
GS181473: GO:0005488 binding
GS175526: HP:0000005 Mode of inheritance
GS184445: GO:0044428 nuclear part
GS124891: N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide interacting genes (MeSH:C063509) in CTD
GS180036: GO:0032501 multicellular organismal process
GS196930: GO:0065007 biological regulation
GS192512: GO:0003824 catalytic activity
GS125345: Prazosin interacting genes (MeSH:D011224) in CTD
GS180644: GO:0032549 ribonucleoside binding
GS171647: HP:0011844 Abnormal appendicular skeleton morphology
GS171638: HP:0003707 Calf muscle pseudohypertrophy
GS182665: GO:0042278 purine nucleoside metabolic process
GS189896: GO:0009117 nucleotide metabolic process
GS173062: HP:0003677 Slow progression
GS181666: GO:0019439 aromatic compound catabolic process
GS129121: cocaine seizure 2 (Cosz2 Published QTL Chr 14)
GS177589: GO:0003208 cardiac ventricle morphogenesis
GS84276: nicotine sensitivity (Published QTL, Chr 14)
GS201249: GO:0044428 nuclear part
GS197244: GO:0044237 cellular metabolic process
GS174804: HP:0009055 Generalized limb muscle atrophy
GS193991: GO:0048731 system development
GS199651: GO:0005198 structural molecule activity
GS173535: HP:0001874 Abnormality of neutrophils
GS204107: GO:0072359 circulatory system development
GS200955: GO:0008307 structural constituent of muscle
GS171721: HP:0003445 EMG: neuropathic changes
GS191982: GO:0030016 myofibril
GS175529: HP:0000001 All
GS188962: GO:1901292 nucleoside phosphate catabolic process
GS193018: GO:0003008 system process
GS199459: GO:0042278 purine nucleoside metabolic process
GS136025: heart weight quantitative locus 1 (Hwq1, Published QTL Chr 14)
GS175527: HP:0000006 Autosomal dominant inheritance
GS178813: GO:0046983 protein dimerization activity
GS184447: GO:0044424 intracellular part
GS189897: GO:0009116 nucleoside metabolic process
GS206737: GO:0043168 anion binding
GS207862: GO:0009056 catabolic process
GS198455: GO:0019439 aromatic compound catabolic process
GS171394: HP:0000174 Abnormality of the palate
GS194519: GO:0014706 striated muscle tissue development
GS183687: GO:0061061 muscle structure development
GS191983: GO:0030017 sarcomere
GS193489: GO:0072521 purine-containing compound metabolic process
GS209863: GO:0050896 response to stimulus
GS210435: GO:0072521 purine-containing compound metabolic process
GS210437: GO:0072523 purine-containing compound catabolic process
GS172822: HP:0003687 Centrally nucleated skeletal muscle fibers
GS173872: HP:0011368 Epidermal thickening
GS177779: GO:0014706 striated muscle tissue development
GS203335: GO:0048513 organ development
GS188684: GO:0070013 intracellular organelle lumen
GS186740: GO:0043229 intracellular organelle
GS198012: GO:0046434 organophosphate catabolic process
GS123299: anacardic acid interacting genes (MeSH:C088115) in CTD
GS191700: GO:0006753 nucleoside phosphate metabolic process
GS210709: GO:0070252 actin-mediated cell contraction
GS186087: GO:0001725 stress fiber
GS205558: GO:0003013 circulatory system process
GS175556: HP:0011675 Arrhythmia
GS123911: Ozone interacting genes (MeSH:D010126) in CTD
GS182475: GO:0043233 organelle lumen
GS193987: GO:0048738 cardiac muscle tissue development
GS193858: GO:0055008 cardiac muscle tissue morphogenesis
GS208012: GO:0044464 cell part
GS87380: Table S1: Additional data file 1 is a table listing the results of two-way ANOVA (FDR < 1%). (Whole Table) [DRG]
GS210212: GO:0005575 cellular_component
GS83995: cocaine seizure 2 (Cosz2, Published QTL, Chr 14)
GS201239: GO:0046483 heterocycle metabolic process
GS173931: HP:0001670 Asymmetric septal hypertrophy
GS123756: Y 27632 interacting genes (MeSH:C108830) in CTD
GS172526: HP:0001699 Sudden death
GS188763: GO:0009888 tissue development
GS188399: GO:0044238 primary metabolic process
GS172355: HP:0002460 Distal muscle weakness
GS184435: GO:0046483 heterocycle metabolic process
GS175577: HP:0003202 Amyotrophy
GS181480: GO:0055010 ventricular cardiac muscle tissue morphogenesis
GS121575: SK-7041 interacting genes (MeSH:C497103) in CTD
GS205825: GO:1901292 nucleoside phosphate catabolic process
GS179580: GO:0036094 small molecule binding
GS204692: GO:0060047 heart contraction
GS201792: GO:0032559 adenyl ribonucleotide binding
GS172578: HP:0003691 Scapular winging
GS205123: GO:0030029 actin filament-based process
GS205623: GO:0009888 tissue development
GS176101: HP:0000924 Abnormality of the skeletal system
GS36778: Cerebellum Gene expression correlates of Zero Maze - Percentage open time in Males BXD
GS190492: GO:0009154 purine ribonucleotide catabolic process
GS123718: Ethinyl Estradiol interacting genes (MeSH:D004997) in CTD
GS176759: HP:0000982 Palmoplantar keratoderma
GS194322: GO:0003206 cardiac chamber morphogenesis
GS174500: HP:0000707 Abnormality of the nervous system
GS193012: GO:0003007 heart morphogenesis
GS177310: GO:1901360 organic cyclic compound metabolic process
GS208384: GO:0016887 ATPase activity
GS171998: HP:0001939 Abnormality of metabolism/homeostasis
GS196896: GO:0009205 purine ribonucleoside triphosphate metabolic process
GS189317: GO:0043292 contractile fiber
GS174442: HP:0001436 Abnormality of the foot musculature
GS196511: GO:0030054 cell junction
GS174071: HP:0009125 Lipodystrophy
GS191457: GO:0016887 ATPase activity
GS195905: GO:0008016 regulation of heart contraction
GS123811: Zinc interacting genes (MeSH:D015032) in CTD
GS34295: Cerebellum Gene expression correlates of Activity in 30 second interval post 3rd tone shock pairing in Males BXD
GS177902: GO:0042802 identical protein binding
GS182834: GO:0005623 cell
GS121965: Amiodarone interacting genes (MeSH:D000638) in CTD
GS177051: HP:0001155 Abnormality of the hand
GS136280: modifier of ocular retardation 3 (Modor3, Published QTL Chr 14)
GS205511: GO:0001882 nucleoside binding
GS197016: GO:0032991 macromolecular complex
GS178448: GO:0005634 nucleus
GS194028: GO:0032432 actin filament bundle
GS174914: HP:0003011 Abnormality of the musculature
GS182474: GO:0043232 intracellular non-membrane-bounded organelle
GS199635: GO:0005622 intracellular
GS125903: HS 142-1 interacting genes (MeSH:C072551) in CTD
GS171461: HP:0011121 Abnormality of skin morphology
GS194304: GO:0009164 nucleoside catabolic process
GS121976: Zidovudine interacting genes (MeSH:D015215) in CTD
GS174814: HP:0001639 Hypertrophic cardiomyopathy
GS176038: HP:0002795 Functional respiratory abnormality
GS196912: GO:0046128 purine ribonucleoside metabolic process
GS203085: GO:0009146 purine nucleoside triphosphate catabolic process
GS186758: GO:0034655 nucleobase-containing compound catabolic process
GS196943: GO:0008152 metabolic process
GS136627: Stem cell proliferation 9 (Scpro9, Published QTL Chr 14)
GS174810: HP:0001635 Congestive heart failure
GS207161: GO:0006928 cellular component movement
GS122142: Dietary Fats interacting genes (MeSH:D004041) in CTD
GS205437: GO:0000302 response to reactive oxygen species
GS205761: GO:0070161 anchoring junction
GS208185: GO:0010035 response to inorganic substance
GS174075: HP:0009121 Abnormal axial skeleton morphology
GS196941: GO:0008150 biological_process
GS199634: GO:0005623 cell
GS135518: body weight 1 (Bwt1, Published QTL Chr 14)
GS208922: GO:0030017 sarcomere
GS126191: candesartan cilexetil interacting genes (MeSH:C077793) in CTD
GS187648: GO:0048729 tissue morphogenesis
GS195876: GO:0030048 actin filament-based movement
GS188368: GO:0015629 actin cytoskeleton
GS201256: GO:0044422 organelle part
GS205616: GO:0009887 organ morphogenesis
GS183169: GO:0031674 I band
GS189900: GO:0009119 ribonucleoside metabolic process
GS209954: GO:0003007 heart morphogenesis
GS201431: GO:0005515 protein binding
GS176613: HP:0000271 Abnormality of the face
GS176973: HP:0001072 Thickened skin
GS177142: GO:0055008 cardiac muscle tissue morphogenesis
GS203649: GO:0030554 adenyl nucleotide binding
GS171897: HP:0011103 Abnormality of the left ventricular outflow tract
GS174070: HP:0009124 Abnormality of adipose tissue
GS187160: GO:0044707 single-multicellular organism process
GS835: Sey_Pax6_Add_Linear_Decrease
GS175016: HP:0001626 Abnormality of the cardiovascular system
GS190682: GO:0007275 multicellular organismal development
GS191954: GO:0005856 cytoskeleton
GS205224: GO:0015629 actin cytoskeleton
GS199267: GO:0043234 protein complex
GS193059: GO:0044446 intracellular organelle part
GS127039: Propranolol interacting genes (MeSH:D011433) in CTD
GS209564: GO:0043231 intracellular membrane-bounded organelle
GS129166: plasma plant sterol 1 (Plast1 Published QTL Chr 14)
GS194504: GO:1901136 carbohydrate derivative catabolic process
GS191422: GO:0030055 cell-substrate junction
GS198511: GO:0006163 purine nucleotide metabolic process
GS175981: HP:0000163 Abnormality of the oral cavity
GS184976: GO:0032559 adenyl ribonucleotide binding
GS190496: GO:0009150 purine ribonucleotide metabolic process
GS125062: palm oil interacting genes (MeSH:C041786) in CTD
GS199272: GO:0043232 intracellular non-membrane-bounded organelle
GS196898: GO:0009203 ribonucleoside triphosphate catabolic process
GS206215: GO:0042454 ribonucleoside catabolic process
GS207263: GO:0042623 ATPase activity, coupled
GS176100: HP:0000925 Abnormality of the vertebral column
GS176228: HP:0000782 Abnormality of the scapula
GS171848: HP:0000598 Abnormality of the ear
GS207385: GO:0009154 purine ribonucleotide catabolic process
GS126498: Dextroamphetamine interacting genes (MeSH:D003913) in CTD
GS175015: HP:0001627 Abnormality of the heart
GS202941: GO:0006936 muscle contraction
GS204021: GO:0044707 single-multicellular organism process
GS205047: GO:0006807 nitrogen compound metabolic process
GS135391: body growth early QTL 13 (Bgeq13, Published QTL Chr 14)
GS184629: GO:0005515 protein binding
GS191961: GO:0005859 muscle myosin complex
GS193195: GO:0016460 myosin II complex
GS208636: GO:0006753 nucleoside phosphate metabolic process
GS187770: GO:1901565 organonitrogen compound catabolic process
GS174660: HP:0001421 Abnormality of the musculature of the hand
GS176900: HP:0000218 High palate
GS127257: spiruchostatin A interacting genes (MeSH:C485419) in CTD
GS194645: GO:0042802 identical protein binding
GS196131: GO:0005924 cell-substrate adherens junction
GS180152: GO:0065007 biological regulation
GS185881: GO:0035639 purine ribonucleoside triphosphate binding
GS179364: GO:0005924 cell-substrate adherens junction
GS197028: GO:0016459 myosin complex
GS86984: Table S2: The data provided represent genes showing differential expression using ANOVA. A. Genes showing main effect of strain. [DRG] provisional
GS185991: GO:0016817 hydrolase activity, acting on acid anhydrides
GS186488: GO:0048513 organ development
GS84275: cocaine seizure (Published QTL, Chr 14)
GS185366: GO:0044248 cellular catabolic process
GS194775: GO:0007517 muscle organ development
GS181932: GO:0003231 cardiac ventricle development
GS194041: GO:1901361 organic cyclic compound catabolic process
GS191030: GO:0007507 heart development
GS129168: plasma plant sterol 1b (Plast1b Published QTL Chr 14)
GS172030: HP:0000365 Hearing impairment
GS192461: GO:0046130 purine ribonucleoside catabolic process
GS201002: GO:0044270 cellular nitrogen compound catabolic process
GS125119: Isoproterenol interacting genes (MeSH:D007545) in CTD
GS173690: HP:0001644 Dilated cardiomyopathy
GS182175: GO:0006152 purine nucleoside catabolic process
GS202716: GO:0035639 purine ribonucleoside triphosphate binding
GS124075: Metoprolol interacting genes (MeSH:D008790) in CTD
GS196806: GO:0032502 developmental process
GS187633: GO:0019693 ribose phosphate metabolic process
GS196553: GO:0005730 nucleolus
GS170965: HP:0000153 Abnormality of the mouth
GS203594: GO:0043226 organelle
GS195665: GO:0017111 nucleoside-triphosphatase activity
GS202919: GO:0001725 stress fiber
GS172667: HP:0011805 Abnormality of muscle morphology
GS200446: GO:0017076 purine nucleotide binding
GS186188: GO:0000146 microfilament motor activity
GS203082: GO:0009143 nucleoside triphosphate catabolic process
GS210002: GO:0044444 cytoplasmic part
GS171168: HP:0000234 Abnormality of the head
GS173157: HP:0003326 Myalgia
GS193491: GO:0072523 purine-containing compound catabolic process
GS184983: GO:0032550 purine ribonucleoside binding
GS174331: HP:0002715 Abnormality of the immune system
GS209960: GO:0003008 system process
GS186235: GO:0009141 nucleoside triphosphate metabolic process
GS184198: GO:0044270 cellular nitrogen compound catabolic process
GS192174: GO:0000166 nucleotide binding
GS203593: GO:0043227 membrane-bounded organelle
GS207524: GO:0003774 motor activity
GS181102: GO:0043228 non-membrane-bounded organelle
GS135791: epilepsy 5 (El5, Published QTL Chr 14)
GS176811: HP:0002792 Reduced vital capacity
GS188896: GO:0070161 anchoring junction
GS191973: GO:0046700 heterocycle catabolic process
GS194505: GO:1901135 carbohydrate derivative metabolic process
GS206183: GO:0043292 contractile fiber
GS174968: HP:0003236 Elevated serum creatine phosphokinase
GS209614: GO:0055086 nucleobase-containing small molecule metabolic process
GS210000: GO:0044446 intracellular organelle part
GS209518: GO:0032982 myosin filament
GS174131: HP:0002011 Abnormality of the central nervous system
GS202316: GO:0050789 regulation of biological process
GS208810: GO:0009259 ribonucleotide metabolic process
GS194087: GO:0003674 molecular_function
GS171424: HP:0002814 Abnormality of the lower limb
GS176336: HP:0009031 Amyotrophy of ankle musculature
GS121343: Flavonoids interacting genes (MeSH:D005419) in CTD
GS177356: GO:0003674 molecular_function
GS203590: GO:0043229 intracellular organelle
GS180001: GO:0048646 anatomical structure formation involved in morphogenesis
GS177717: GO:0051239 regulation of multicellular organismal process
GS177309: GO:1901363 heterocyclic compound binding
GS179110: GO:0030049 muscle filament sliding
GS124534: Norepinephrine interacting genes (MeSH:D009638) in CTD
GS172839: HP:0010674 Abnormality of the curvature of the vertebral column
GS176610: HP:0003593 Infantile onset
GS175119: HP:0001881 Abnormality of leukocytes
GS174813: HP:0001638 Cardiomyopathy
GS194320: GO:0003205 cardiac chamber development
GS136712: susceptibility to lung cancer 13 (Sluc13, Published QTL Chr 14)
GS180166: GO:0008152 metabolic process
GS177298: GO:0032432 actin filament bundle
GS176806: HP:0003812 Phenotypic variability
GS203083: GO:0009144 purine nucleoside triphosphate metabolic process
GS171832: HP:0000118 Phenotypic abnormality
GS192906: GO:0006200 ATP catabolic process
GS203886: GO:1901265 nucleoside phosphate binding
GS173065: HP:0003679 Pace of progression
GS180248: GO:0016459 myosin complex
GS174443: HP:0001437 Abnormality of the musculature of the lower limbs
GS177023: HP:0010876 Abnormality of circulating protein level
GS177382: GO:0097159 organic cyclic compound binding
GS175557: HP:0002515 Waddling gait
GS192253: GO:0005912 adherens junction
GS124781: Monocrotaline interacting genes (MeSH:D016686) in CTD
GS171251: HP:0003549 Abnormality of connective tissue
GS203028: GO:0000146 microfilament motor activity
GS187193: GO:0044057 regulation of system process
GS189844: GO:0009261 ribonucleotide catabolic process
GS184978: GO:0032555 purine ribonucleotide binding
GS172040: HP:0000962 Hyperkeratosis
GS172989: HP:0001324 Muscle weakness
GS184154: GO:0008307 structural constituent of muscle
GS205543: GO:0070013 intracellular organelle lumen
GS177903: GO:0042803 protein homodimerization activity
GS177766: GO:1901135 carbohydrate derivative metabolic process
GS208921: GO:0030016 myofibril
GS173787: HP:0002813 Abnormality of limb bone morphology
GS186237: GO:0009143 nucleoside triphosphate catabolic process
GS188322: GO:0005524 ATP binding
GS192577: GO:0032982 myosin filament
GS195214: GO:0009987 cellular process
GS206784: GO:0009119 ribonucleoside metabolic process
GS184452: GO:0044422 organelle part
GS180034: GO:0032502 developmental process
GS193193: GO:0016462 pyrophosphatase activity
GS177841: GO:0048644 muscle organ morphogenesis
GS175673: HP:0100022 Abnormality of movement
GS122186: Dinoprostone interacting genes (MeSH:D015232) in CTD
GS202370: GO:0006979 response to oxidative stress
GS201794: GO:0032555 purine ribonucleotide binding
GS195888: GO:0060415 muscle tissue morphogenesis
GS199374: GO:0042641 actomyosin
GS125634: trichostatin A interacting genes (MeSH:C012589) in CTD
GS203642: GO:0006725 cellular aromatic compound metabolic process
GS125409: Triiodothyronine interacting genes (MeSH:D014284) in CTD
GS174917: HP:0000765 Abnormality of the thorax
GS174335: HP:0001871 Abnormality of blood and blood-forming tissues
GS175714: HP:0011389 Functional abnormality of the inner ear
GS207923: GO:0034641 cellular nitrogen compound metabolic process
GS187023: GO:1901265 nucleoside phosphate binding
GS86906: Table S1: Additional data file 1 is a table listing the results of two-way ANOVA (FDR < 1%). Lists of probe sets and gene names altered by strain (3457). [DRG] provisional
GS188268: GO:0030029 actin filament-based process
GS179748: GO:0030054 cell junction
GS192296: GO:0006796 phosphate-containing compound metabolic process
GS198263: GO:0005488 binding
GS199969: GO:0031674 I band
GS173749: HP:0001465 Amyotrophy involving the shoulder musculature
GS187249: GO:0072358 cardiovascular system development
GS194040: GO:1901360 organic cyclic compound metabolic process
GS208346: GO:0030055 cell-substrate junction
GS177765: GO:1901136 carbohydrate derivative catabolic process
GS195151: GO:0019637 organophosphate metabolic process
GS206182: GO:0060537 muscle tissue development
GS125669: Phenylephrine interacting genes (MeSH:D010656) in CTD
GS186798: GO:0030554 adenyl nucleotide binding
GS191870: GO:0009259 ribonucleotide metabolic process
GS170971: HP:0000407 Sensorineural hearing impairment
GS208037: GO:0016787 hydrolase activity
GS136088: lean body mass 10 (Lbm10, Published QTL Chr 14)
GS179139: GO:0008016 regulation of heart contraction
GS209235: GO:0006793 phosphorus metabolic process
GS172766: HP:0001682 Subvalvular aortic stenosis
GS124312: sodium arsenite interacting genes (MeSH:C017947) in CTD
GS178028: GO:0007517 muscle organ development
GS204496: GO:0019693 ribose phosphate metabolic process
GS207935: GO:0007507 heart development
GS187833: GO:0060047 heart contraction
GS126328: Angiotensin-Converting Enzyme Inhibitors interacting genes (MeSH:D000806) in CTD
GS84277: METH responses for home cage activity (Published QTL, Chr 14)
GS180120: GO:0009205 purine ribonucleoside triphosphate metabolic process
GS205557: GO:0003012 muscle system process
GS180452: GO:0044237 cellular metabolic process
GS209852: GO:0006200 ATP catabolic process
GS123782: GC 1 compound interacting genes (MeSH:C413355) in CTD
GS171754: HP:0001711 Abnormality of the left ventricle
GS182469: GO:0043234 protein complex
GS195570: GO:0046983 protein dimerization activity
GS188751: GO:0044430 cytoskeletal part
GS180164: GO:0008150 biological_process
GS175579: HP:0003200 Ragged-red muscle fibers
GS175811: HP:0011021 Abnormality of circulating enzyme level
GS174812: HP:0001637 Abnormality of the myocardium
GS205972: GO:0008015 blood circulation
GS203080: GO:0009141 nucleoside triphosphate metabolic process
GS205179: GO:0005524 ATP binding
GS205255: GO:0044238 primary metabolic process
GS186108: GO:0006936 muscle contraction
GS196772: GO:0048646 anatomical structure formation involved in morphogenesis
GS180236: GO:0032991 macromolecular complex
GS176756: HP:0011420 Death
GS186562: GO:0009653 anatomical structure morphogenesis
GS187769: GO:1901564 organonitrogen compound metabolic process
GS206780: GO:0009117 nucleotide metabolic process
GS209232: GO:0006796 phosphate-containing compound metabolic process
GS175994: HP:0000464 Abnormality of the neck
GS190954: GO:0009056 catabolic process
GS209455: GO:0003824 catalytic activity
GS177813: GO:0031974 membrane-enclosed lumen
GS184218: GO:0071704 organic substance metabolic process
GS192610: GO:0031981 nuclear lumen
GS202822: GO:0016818 hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides
GS172731: HP:0011463 Childhood onset